Biomedical Engineering Reference
In-Depth Information
(
A
)
(
B
)
Figure 9.25
(
A
) Full-thickness ulceration and deep erosions are seen following trichloroacetic acid peeling that penetrated too deeply. (
B
) Treatment was initially
begun with oral antibiotics and ultrathin Duoderm. Once the ulcerations had healed, intralesional 5-FU (45 mg/cc) and triamcinolone (1 mg/cc) were used to
control hypertrophic scars that developed. The V-beam Perfecta and Fraxel Re:Store were used to normalize the scar tissue.
references
1. Sund B. New Developments in Wound Care. London: PJB Publications,
2000: 1-255.
2. Tsao SS, Dover JS, Arndt KA, Kaminer MS. Scar management: keloid,
hypertrophic, atrophic, and acne scars. Sem Cut Med Surg 2002; 21:
46-75.
3. Breasted JH. The Edwin Smith Surgical Papyrus: Hieroglyphic Transac-
tion and Commentary. Chicago: University of Chicago Press, 1970: 403-6.
4. Addison T. On the keloid of alibert and on true keloids. Med Chir Trans
1835; 19: 19.
5. Mancini RE, Quaife JV. Histogenesis of experimentally produced keloids.
J Invest Dermatol 1962; 38: 143-81.
6. Roseborough IE, Grevious MA, Lee RC. Prevention and treatment of
excessive dermal scarring. J Nat Med Assoc 2004; 96: 108-16.
7. Niessen FB, Sapuwen PH, Schalkwijk J, Kon M. On the nature of
hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999; 104:
1435-58.
8. Murray CJ, Pinnel SR. Keloids and excessive dermal scarring. In: Cohen
IK, Diegelmann RF, Lindblad WJ, eds. Woundhealing, Biochemical and
Clinical Aspects. Philadelphia: Saunders Elsevier, 1992: 500-9.
9. Murray JC. Keloids and hypertrophic scars. Clin Dermatol 1994; 12:
27-37.
10. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and
scars, their pathogenesis, risk factors, and management. Curr Opin
Pediatr 2006; 18: 396-402.
11. Sephel GC, Woodward SC. Repair, regeneration, and fi brosis. In: Rubin
E, ed. Rubin's Pathology. Baltimore: Lippincott, Williams & Wilkins,
2001: 84-117.
12. Diegelmann RF, Cohen IK, McCoy B. Growth kinetics and collagen
synthesis of normal skin, scar and keloid fi broblasts in vitro. J Cell
Physiol 1979; 98: 341-6.
13. Cohen IK, Keiser HR, Sjoerdsmo A. Collagen synthesis in human
keloid and hypertrophic scars. Surg Forum 1971; 22: 488.
14. Chung S, Nakashima M, Zembutsu H, Nakamura Y. Possible involve-
ment of NEDD4 in keloid formation; its critical role in fi broblast
proliferation and collagen production. Proc Jpn Acad Ser B Phys Biol
Sci 2011; 87: 563-73.
15. Dienus K, Bayat A, Gilmore BF, Seifert O. Increased expression of fi bro-
blast activation protein-alpha in keloid fi broblasts: Implications for
development of a novel treatment option. Arch Dermatol Res 2010;
302: 725-31.
16. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic
scarring and keloids: pathomechanisms and current and emerging treat-
ment strategies. Mol Med 2011; 17: 113-25.
17. Bond JS, Duncan JA, Sattar A, et al. Maturation of the human scar: an
observational study. Plast Reconstr Surg 2008; 121: 1650-8.
18. Bond JS, Duncan JA, Mason T, et al. Scar redness in humans: how long
does it persist after incisional and excisional wounding? Plast Reconstr
Surg 2008; 121: 487-96.
19. Ladak A, Tredget EE. Pathophysiology and management of the burn
scar. Clin Plast Surg 2009; 36: 661-74.
20. Ginsbach G, Kuhnel W. The treatment of hypertrophic scars and
keloids by argon laser: Clinical data and morphological fi ndings. Plast
Surg Forum 1979; 1: 61-7.
21. Hulsbergen-Henning JP, Roskann Y, vanGemert M. Treatment of
keloids and hypertrophic scars with an argon laser. Lasers Surg Med
1986; 6: 72-5.
22. Apfelberg DB, Maser MR, Lash H, et al. Preliminary results of argon
and carbon dioxide laser treatment of keloid scars. Lasers Surg Med
1984; 4: 283-90.
23. Bailin P. Use of the CO
2
laser for non-PWS cutaneous lesions. In: Arndt
KA, Noe JM, Rosen S, eds. Cutaneous Laser Therapy: Principles and
Methods. New York, NY: John Wiley, 1983: 187-200.
24. Norris TE. The effect of carbon dioxide laser surgery on the recurrence
of keloids. Plast Reconstr Surg 1991; 87: 44-9.
25. Olbricht SM, Arndt KA. Lasers in cutaneous surgery. In: Fuller T, ed.
Surgical Lasers: A Clinical Guide. New York, NY: MacMillan, 1987:
113-46.
26. Bernstein LJ, Kauvar ANG, Grossman MC, et al. Scar resurfacing and
high-energy, short-pulsed and fl ashscanning carbon dioxide lasers.
Dermatol Surg 1998; 24: 101-7.
27. Goldman MP, Fitzpatrick RE. Cutaneous Laser Surgery: The Art and Sci-
ence of Selective Photothermolysis, 2nd edn. St. Louis, MO: Mosby, Inc,
1999.
28. Nouri K, Laser treatment of scars. In: Elston D, ed. Drugs, Diseases and
Procedures. New York: Medscape.com, 2010.
29. Anderson RR, Parrish JA. Selective photothermolysis: precise micro-
surgery by selective absorption of pulsed radiation. Science 1983;
22: 524-7.
30. Alster TS, Kurban AK, Grove GL, et al. Alteration of argon laser-induced
scars by the pulsed dye laser. Lasers Surg Med 1993; 13: 368-73.
31. Alster TS. Improvement of erythematous and hypertrophic scars by
the 585 nm pulsed dye laser. Ann Plast Surg 1994; 32: 186-90.
32. Dierickx C, Goldman MP, Fitzpatrick RE. Laser treatment of erythem-
atous /hypertrophic and pigmented scars in 26 patients. Plast Reconstr
Surg 1995; 95: 84-90.
33. Goldman M, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg
1995; 21: 685-7.
